![]() |
![]() |
|
Hello ! 2009 January SymposiumBy Tracy Blancas, Professional Development ChairLisa Stockwell Morris, PhD, global director for IMS LifeLink, commented, “The complexity of today’s healthcare market has propelled patient-level data to the forefront, better helping pharmaceutical company marketers to drive improved business outcomes.” We agree. To help our colleagues in management science understand the applications for patient-level data, we have developed a Symposium entitled “Capitalizing on Advanced Analytics Using Patient-Level Data”, scheduled for January 20 - 21, 2009 at the Hyatt Regency, New Brunswick, NJ. Our January two-day Symposium will provide both practical and theoretical insights into utilization of Patient-Level Data (PLD) – the latest trend enabling better and faster decision-making on marketing, sales operations, portfolio analysis, managed markets, and clinical therapeutic pursuits. The Symposium will address current and emerging analytic application uses in marketing and sales with hands-on “live” manufacturer case studies, best practices for working with brand marketing, analytics teams and PLD data vendors, and how some of the manufacturer challenges utilizing PLD are being addressed, with PLD expert lecturers and facilitators from ZS Associates, SDI, IMS, Wolters-Kluwer, and SAS Life Sciences. The registration will open in late November on PMSA's website, www.pmsa.net. The early bird rate of $795 for this two full-day Symposium is available until January 5, 2009, after which the program cost will be $895. Please watch our website closely for additional details. Back to top Patient-Level Data Suppliers: Is Data Dumping Trashed? By Daniel J. Feldman, PhD, President Almost every manufacturer and consultant in the pharmaceutical industry is touched by pharmacy- and claim-level data, and over the last decade, it would be nearly impossible not to notice the explosion of patient-level data and the analytics that capitalize on their availability. It would be equally challenging to ignore the mergers, acquisitions, deals, and spin-offs that make the patient-level data suppliers mirror the manufacturer industry that they so adeptly support. The most recent announcements to rock the data world are the SDI-Verispan merger, the Wolters Kluwer Health acquisition of UpToDate electronic medical records, and IMS’ enhancements to its LifeLink portfolio of patient-level products. With all this talk about more data, it is reasonable to wonder if PMSA members will soon be flooded. What good is the best-prepared banquet if you don't have the utensils to consume it? Will these suppliers provide the forks alongside the feast? Below are the responses of these suppliers and the overall themes of their responses. SDI Theme: Partnerships Wolters Kluwer Health Theme: Advanced Analytics IMS Theme: Easy-to-use Applications SDI expects their data and tool integration to be completed by the end of this year or early in 2009. The acquisition of UpToDate by Wolters Kluwer Health is currently targeted by the end of the year pending regulatory approval. IMS LifeLink is currently available to customers. Back to top PMSA Website Update - Create Your Profile and Wiki Social networking is becoming an increasingly important part of everyday business life, especially with the advent of new technologies. PMSA is capitalizing on this trend and is working on adding member profiles (like LinkedIn™ and Facebook™) and an industry-specific Wiki tool (like Wikipedia™ ) for management scientists. Soon you will be able to post your topics and solutions to common industry questions, as well as create and update your profile and contact information, connect to colleagues, and share your innovations with the PMSA community year-round. Why wait for the annual conference? Check back to the website soon and often for updates … Back to top Contact Information
To remove yourself from this mailing list, click here. Back to top
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||